• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.

作者信息

Pilger E, Lammer J, Bertuch H, Steiner H

出版信息

Radiology. 1986 Dec;161(3):597-9. doi: 10.1148/radiology.161.3.3786705.

DOI:10.1148/radiology.161.3.3786705
PMID:3786705
Abstract

In order to investigate and compare the fibrinolytic activity of streptokinase, streptokinase-Glutamine-plasminogen, and urokinase for intraarterial fibrinolysis, as in vitro test and a prospective trial were performed. For the in vitro demonstration of lytic activity, fibrin plates with plasminogen and fibrin plates without plasminogen were incubated with streptokinase; with streptokinase-plasminogen in molar proportions of 1:1, 1:2, and 2:1, and with urokinase. In order to examine the in vivo activity of the different lytic solutions, 98 patients suffering from peripheral arterial occlusions were divided into three homogeneous groups for treatment with streptokinase, streptokinase-plasminogen, and urokinase. Although urokinase was superior to streptokinase on the fibrin plate with plasminogen, no difference was demonstrated in vivo between the two lytic agents. Streptokinase-plasminogen in a molar proportion of 1:2 showed significantly higher fibrinolytic activity than any other solution. Therefore, the fibrinolytic agent of choice for intrathrombotic injections seems to be a 1:2 solution of streptokinase with plasminogen or with the lytic enzyme plasmin itself.

摘要

相似文献

1
Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
Radiology. 1986 Dec;161(3):597-9. doi: 10.1148/radiology.161.3.3786705.
2
[New thrombolytic agents in myocardial infarction].[心肌梗死中的新型溶栓药物]
Arch Mal Coeur Vaiss. 1987 Nov;80(12):1785-91.
3
The search for the ideal thrombolytic agent.对理想溶栓剂的探索。
J Am Coll Cardiol. 1987 Nov;10(5 Suppl B):4B-10B. doi: 10.1016/s0735-1097(87)80421-7.
4
[Thrombolytic treatment of arteriopathies. Do thrombolytics compete with surgery?].[动脉病的溶栓治疗。溶栓剂与手术相竞争吗?]
Haemostasis. 1986;16 Suppl 4:87-9. doi: 10.1159/000215537.
5
[Thrombolytics and their use].[溶栓剂及其应用]
Rev Prat. 1999 Oct 1;49(15):1654-8.
6
The systemic fibrinolytic effect of BRL 26921 during the treatment of acute peripheral arterial occlusions.BRL 26921在急性外周动脉闭塞治疗过程中的全身纤溶作用。
Thromb Haemost. 1986 Apr 30;55(2):259-62.
7
Drug variables in thrombolytic therapy.溶栓治疗中的药物变量。
J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):62S-65S. doi: 10.1016/s1051-0443(95)71250-7.
8
Intraarterial fibrinolytic therapy for popliteal and tibial artery obstruction: comparison of streptokinase and urokinase.
AJR Am J Roentgenol. 1987 Sep;149(3):453-6. doi: 10.2214/ajr.149.3.453.
9
[The administration of thrombolytic agents in peripheral vascular occlusion].[外周血管闭塞中溶栓药物的应用]
Ned Tijdschr Geneeskd. 1988 Sep 24;132(39):1785-9.
10
Fibrin-specific thrombolytic agents.纤维蛋白特异性溶栓剂。
Schweiz Med Wochenschr. 1987 Nov 14;117(46):1791-8.